von übernahme habe ich auch nichts gefunden, ich weiß nicht, ob du diese news kennst (hier geht wieder um "hot stocks", news sind von heute):
Stock Market Alerts LLC: Hot Stock Lists for Wednesday! July 12, 2006
7/12/2006
Miami, FLA., Jul 12, 2006 (M2 PRESSWIRE via COMTEX News Network) --
Stock Market Alert's performance stock list includes: ER Urgent Care Centers (OTC: ERUG), Samaritan Pharmaceuticals Inc. (AMEX: LIV), Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX), Cambridge Heart, Inc. (OTCBB: CAMH), Grant Life Sciences Inc. (OTCBB: GLIF).
ER Urgent Care Centers (OTC: ERUG) should be of interest to speculative investors this morning. Yesterday the company issued a press release announcing that it has received a highly favorable report from an independent market analyst. ERUG is happy to report that the independent analysis speaks very highly as to the direction the company is going. Also in the analysis is that the methods being used by the company are on target in a booming industry.
This should be a stock for speculative investors to watch. The press release states ER Urgent (Care Centers) continues to grow in South Florida as well as nationwide. ER Urgent Care currently operates five locations in South Florida and another in Kansas City. Over the next two years, a plan of consistent growth in major markets is on tap for ER Urgent Care Centers. As community service programs are implemented in each of these communities, a steady expansion plan is in place.
ERUC Management Company Inc. operates ER Urgent Care Centers in the South Florida area. The "true, bona-fide," "Urgent Care Center" is a one-stop-shop where patients can receive premier health care, after-hours, at a fraction of the cost of emergency room visits. With the "Urgent Care Center" model, emergency rooms will no longer lose money on ER patients with minor injuries and illnesses, and the HMOs will no longer have to pay exorbitant claims for non-admitted patients. ER Urgent Care Centers create a win-win situation for everyone, filling the financial and service gap between primary care physicians (PCPs) and hospital emergency rooms.
Other Stocks of interest yesterday were:
Samaritan Pharmaceuticals Inc. (AMEX: LIV) up 30.7% on 2.6 million shares traded.
Samaritan is a small-cap Biotech, driven to discover, develop and commercialize innovative therapeutics' for AIDS, Alzheimer's, Cancer and Heart disease patients. Samaritan Pharmaceuticals Inc. recently announced, its Alzheimer's drug SP-233 (Caprospinol), not only stops amyloid plaque formation in the brain of an animal model for Alzheimer's disease but also shows that treatment with Caprospinol, results in the complete disappearance of amyloid plaques in the brain.
Idenix Pharmaceuticals, Inc. (NASDAQ: IDIX) up 13.1% on 995,000 shares traded.
Idenix Pharmaceuticals, Inc. is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix Pharmaceuticals, Inc. recently announced that Jean-Pierre Sommadossi, Ph.D., Idenix's chairman and chief executive officer, will present a corporate overview at the upcoming Pacific Growth Equities Life Sciences Growth Conference on Monday, June 12, 2006 at 9:00 a.m. PT at the InterContinental Mark Hopkins Hotel in San Francisco, at the Goldman Sachs 27th Annual Global Healthcare Conference on Tuesday, June 13, 2006 at 8:40 a.m. PT at the Ritz Carlton Laguna Niguel, and at the Needham and Co. Fifth Annual Biotechnology and Medical Technology Conference on Thursday, June 15, 2006 at 9:30 am ET at the New York Palace Hotel.
Cambridge Heart, Inc. (OTCBB: CAMH) up 8% on 986,000 shares traded.
Cambridge Heart is engaged in the research, development and commercialization of products for the non-invasive diagnosis of cardiac disease. Cambridge Heart, Inc. recently announced that it has hired Mr. Mark Florence as its Vice President, Sales and Marketing. Mr. Florence has extensive experience over the last 20 years in the cardiac medical device and diagnostic industry. He has held positions of increasing responsibility in marketing, sales and general management with industry leaders such as Abbott Laboratories, Bayer and the Moore Medical Subsidiary of McKesson.
Grant Life Sciences Inc. (OTCBB: GLIF) down 7.2% on 34.7 million shares traded.
Grant Life Sciences, Inc. is a development stage company, engages in the research, development, marketing, and sale of diagnostic kits for the screening, monitoring, and diagnosis of diseases with emphasis on women's health, infectious diseases, and cancers.
Grant Life Sciences Inc. recently announced it has extended through Sept. 2006 its Memo of Understanding (MOU) with Israel-based Diagnostic Technology Ltd. (DTL) related to Grant's cervical cancer-diagnostic technology (U.S. Patent No. 6,743,593).
Under the MOU, Grant will receive an upfront payment of $250,000 upon successful completion of DTL's due diligence and the subsequent signing of a Licensing Agreement. Under the Licensing Agreement, DTL would assume all costs and efforts associated with commercialization of products, including clinical trials, developed by DTL from Grant's cervical cancer-diagnostic technology platform. Upon commercialization, DTL would pay Grant an ongoing royalty on sales of the products developed, according to the MOU.
Wall Street Enews is a Sponsor of Quality Stocks. Quality Stocks tracks the stock picks of 150 Investment Newsletters every day and reports on their performance. For Their Free Service, Visit www.qualitystocks.net.
The advertisement is provided by Wall Street Enews, a division of Stock Market Alerts LLC, an electronic broadcaster and publisher of this release, and hereafter referred to as "the company". The company received compensation for services performed, past and present, for ER Urgent Care Centers (OTC: ERUG). The compensation is five thousand dollars from ER Urgent Care Centers. Because the company received compensation for its services, there is an inherent conflict of interest in the company statements and opinions and such statements and opinions cannot be considered independent.
The information contained in this press release is for informational purposes only, and not to be construed as an offer to sell or solicitation of an offer to buy any security. The company makes no representation or warranty relating to the validity of the facts presented nor does the company represent or warrant that all material facts necessary to make an investment decision are presented above. Stock Market Alerts LLC is an advertising company and therefore, this release should be viewed for informational purposes only.
The company relies exclusively on information gathered on the public company, such as public filings, press releases and its web sites. Investors should use the advertising information contained in this release as a starting point for conducting additional research on the public company in order to allow the investor to form his or her own opinion regarding the public company. Factual statements contained in this publication are made as of the date stated and they are subject to change without notice. The company is not a registered investment adviser, broker or a dealer.
Investing in the public company that this release is providing service for should be reviewed as speculative and a high-risk and may result in the loss of some or all of any investment.
This release may contain statements that constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended. The words "may," "would," "will," "expect," "estimate," "anticipate," "believe," "intend," and similar expressions and variations thereof are intended to identify forward-looking statements.
CONTACT: e-mail: info@wallstreetenews.com
|
Thread abonnieren
